HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹43.28
Day range
₹42.37 - ₹43.50
Year range
₹40.76 - ₹92.81
Market cap
2.38B INR
Avg Volume
66.55K
P/E ratio
12.59
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 707.42M | 7.80% |
Operating expense | 274.96M | 53.69% |
Net income | 2.90M | -95.52% |
Net profit margin | 0.41 | -95.85% |
Earnings per share | — | — |
EBITDA | 41.13M | -59.16% |
Effective tax rate | 67.89% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 407.03M | -34.95% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.32B | — |
Shares outstanding | 55.21M | — |
Price to book | 1.03 | — |
Return on assets | — | — |
Return on capital | 3.23% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.90M | -95.52% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
